| Financial Year |
March 31 2023 |
| Monetary Funds |
527,156,519.49 |
| Held-for-trading Financial Assets |
450,729.92 |
| Notes Receivable |
436,897.91 |
| Accounts Receivable |
167,237,770.55 |
| Advances to Suppliers |
194,390,245.48 |
| Other Receivables |
198,864,372.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
435,268,724.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
732,627,534.00 |
| Total Current Assets |
2,256,432,794.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
364,297,000.62 |
| Investment Properties |
-- |
| Fixed Assetes |
246,497,212.74 |
| Under-construction Projects |
7,332,540.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,757,039.99 |
| R&D expenses |
-- |
| Goodwill |
59,056,682.35 |
| Long-Term Deferred and Prepaid Expenses |
6,644,353.32 |
| Deferred Income Tax Assets |
34,843,531.43 |
| Other Non-Current Assets |
25,355,220.20 |
| Sub-Total of Non-Current Assets |
1,007,717,527.43 |
| Total Assets |
3,264,150,321.56 |
| Short-Term Loans |
1,132,726,669.90 |
| Trading Financial liabilities |
2,591,147.00 |
| Notes Payable |
222,899,594.22 |
| Accounts Payable |
100,928,961.55 |
| Accounts Received In Advance |
12,251.55 |
| Employee Compensation Payable |
13,426,012.24 |
| Taxes Payable |
11,897,618.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
233,223,849.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,145,686.66 |
| Other Current Liabilities |
7,787,761.93 |
| Sub-Total of Current Liabilities |
1,751,733,029.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,395,407.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,422,500.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,707,318.18 |
| Total Liabilities |
1,770,440,347.72 |
| Paid-In Capital(Or Share Stock) |
690,897,549.00 |
| Capital Surplus |
1,093,463,719.08 |
| Surplus Reserve |
161,617,262.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-329,191,490.97 |
| Minority Stockholder's Interest |
33,048,367.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,460,661,606.70 |
| Owner's Equity（Stockholder's Equity） |
1,493,709,973.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,264,150,321.56 |
